0

Explore original, structured summaries for research and education.

Research profile

HCG(Human Chorionic Gonadotropin)

(Human Chorionic Gonadotropin)

HCG(Human Chorionic Gonadotropin) is indexed as a Heterodimeric glycoprotein research entry. Its current evidence category is (Human Chorionic Gonadotropin), and published discussion commonly places it within Sexual Health. This profile summarizes identifiers and literature signals; it does not provide treatment or dosing advice.

Sexual Health

Identity

Molecular Data

Molecular weight
36,700 Da
Chain length
237 amino acids (alpha: 92, beta: 145)
Type
Heterodimeric glycoprotein
Reported half-life
24-36 hours

Literature map

Research indications

Male Fertility

  • TRT Adjunctmost effective
  • Hypogonadotropic Hypogonadismmost effective
  • Post-Cycle Therapyeffective

Female Fertility

  • Ovulation Inductionmost effective

Pediatric

  • Cryptorchidismmoderate

Evidence-gated guidance

Dosing Protocols

A medicine-related record exists, but this profile does not yet contain an independently verified, jurisdiction-specific prescribing schedule. Use only the current authorized product label and a licensed clinician’s directions.

Dose
Not established on this profile
Frequency
Not established on this profile
Cycle
Not established on this profile
Storage
Follow the exact supplier or authorized product documentation; requirements vary by formulation
Open peptide calculator →

Combination risks

Interactions

Evidence status

No independently verified interaction table is available here for HCG(Human Chorionic Gonadotropin). Interaction risk depends on identity, formulation, medicines, supplements, and health conditions.

Do not infer compatibility

Being listed beside another compound does not mean that combining them is safe or effective.

Evidence-informed overview

What to Expect

Evidence boundary

Research indications describe topics studied in the literature; they do not predict an individual outcome.

Clinical monitoring

Where an authorized medicinal use exists, expectations and monitoring should come from the current product label and treating clinician.

Risk overview

Side Effects & Safety

The safety profile of HCG(Human Chorionic Gonadotropin) cannot be inferred from category or molecular identity alone. Research-only materials are not medicines and should not be used in humans.

Verification

Quality Checklist

  1. Confirm exact chemical identity, sequence, salt form, and concentration.
  2. Require a batch-specific certificate of analysis with named test methods and results.
  3. Check manufacturer, lot, expiry, tamper evidence, and documented chain of custody.
  4. For laboratory work requiring sterility, verify sterility and endotoxin testing separately from purity.

Clear answers

Frequently Asked Questions

Is HCG(Human Chorionic Gonadotropin) approved for personal use?

An approved medicine-related record may exist, but approval depends on the exact active ingredient, product, indication, formulation, and country. Check the current local regulator and product label.

Why is no dose listed?

A dose is shown only when it has been checked against a current authoritative prescribing label. Speculative or community regimens are intentionally excluded.

Do research indications prove effectiveness?

No. They organize literature topics and evidence signals; they are not treatment recommendations or guarantees.

Source trail

References

  1. Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men with Testosterone-Induced Gonadotropin SuppressionCoviello AD, Matsumoto AM, Bremner WJ, et al. · Journal of Clinical Endocrinology & Metabolism · 2005
  2. Human Chorionic Gonadotropin Monotherapy for the Treatment of Hypogonadal Symptoms in Men with Total Testosterone >300 ng/dLAlder NJ, Waguih WI, et al. · International Journal of Impotence Research · 2019
  3. Fertility Induction in Hypogonadotropic Hypogonadal MenRastrelli G, Corona G, Mannucci E, Maggi M · Endocrine Reviews · 2018
  4. The Effectiveness of hCG and LHRH in Boys with Cryptorchidism: A Meta-Analysis of Randomized Controlled TrialsDefined a, et al. · Asian Journal of Andrology · 2016
  5. Efficacy and Safety of Human Chorionic Gonadotropin for Treatment of Cryptorchidism: A Meta-Analysis of Randomised Controlled TrialsDefined a, et al. · Journal of Pediatric Surgery · 2018

View the structural source profile ↗